特發性肺纖維化急性加重的研究進展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

代靜泓 ,  蔡后榮

Corresponding?author：

蔡后榮, Email: caihourong@yahoo.com.cn

Keywords：

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 代靜泓,蔡后榮. 特發性肺纖維化急性加重的研究進展. Chinese Journal of Respiratory and Critical Care Medicine, 2009, 09(1): 91-94. doi: Copy

1.	American Thoracic Society/ European Respiratory Society. American Thoracic Society/ European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med, 2002, 165: 277-304.
2.	Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med, 2001, 345: 517-525.
3.	Kondoh Y, Taniguchi H, Kawabata Y, et al. Acute exacerbation in idiopathic pulmonary fibrosis: analysis of clinical and pathologic findings in three cases. Chest, 1993, 103: 1808-1812.
4.	Akira M, Hamada H, Sakatani M, et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis.Am J Roentgenol, 1997, 168: 79-83.
5.	Parambil JG, Myers JL, Ryu JH. Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest, 2005, 128:3310-3315.
6.	Ambrosini V, Cancellieri A, Chilosi M, et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J, 2003 ,22: 821-826.
7.	Kim DS, Park JH, Park BK, et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J,2006, 27: 143-150.
8.	Martinez FJ, Safrin S, Weycker D, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med, 2005 ,142: 963-967.
9.	Daniels CE, Yi ES, Ryu JH. Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis. Eur Respir J, 2008, 32 :170-174.
10.	Collard HR, Moore BB, Flaherty KR, et al. Acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2007 , 176 :636-643.
11.	Hyzy R, Huang S, Myers J, et al. Acute exacerbation of idiopathic pulmonary fibrosis. Chest, 2007, 132: 1652-1658.
12.	Colby TV. Interstitial disease. In: Colby TV, Lombard CM, Yousem SA, Kitaichi M, eds. Atlas of Pulmonary Surgical Pathology.Philadelphia,WB Saunders, 1991, 227-306.
13.	Kitaichi M. Pathologic features and classification of interstitial pnueumonia of unknown etiology. Bull Chest Dis Res Inst Kyoto Univ, 1990, 23: 1-18.
14.	Azuma A, Nukiwa T, Tsuboi E, et al. Placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2005, 171: 1040-1047.
15.	Kubo H, Nakayama K, Yanai M, et al. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest, 2005, 128: 1475-1482.
16.	Rice AJ,Wells AU, Bouros D, et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias. Am J Clin Pathol, 2003 , 119 :709-714.
17.	Churg A, Muller NL, Silva CI, et al. Acute exacerbation ( acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am J Surg Pathol, 2007, 31: 277-284.
18.	Yonemaru M, Kasuga I, Kusumoto H, et al. Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis. Eur Respir J, 1997, 10: 2040-2045.
19.	Tang YW, Johnson JE, Browning PJ, et al. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol, 2003, 41: 2633-2640.
20.	McMillan R, Moore BB, Weinberg JB, et al. Exacerbation of established Pulmonary Fibrosis in a Murine Model by Gammaherpesvirus.AmJ Respir Crit Care Med, 2008, 177: 771-780.
21.	Raghu G, Freudenberger TD, Yang S, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J, 2006 , 27: 136 -142.
22.	Raghu G, Yang ST, Spada C, et al. Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series. Chest, 2006, 129: 794-800.
23.	Agarwal R, Jindal SK. Acute exacerbation of idiopathic pulmonary fibrosis: A systematic review. Eur J Intern Med, 2008 , 19: 227 -235.
24.	Selman M, Thannickal VJ, Pardo A, et al. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs, 2004 , 64 :405-430.
25.	Mehrad B, Burdick MD, Zisman DA, et al. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun, 2007, 353: 104-108.
26.	Yuksel M, Ozyurtkan MO, Bostanci K, et al. Acute exacerbation of interstitial fibrosis after pulmonary resection. Ann Thorac Surg,2006, 82: 336-338.
27.	Yokoyama A, Kohno N, Hamada H, et al. Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 1998, 158: 1680-1684.
28.	Akira M, Kozuka T, Yamamoto S, et al. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2008, 178: 372-378.
29.	Wuyts WA, Thomeer M, Dupont LJ, et al. An algorithm to tackle acute exacerbations in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2008, 177: 1397-1397.
30.	Homma S, Sakamoto S, Kawabata M, et al. Cyclosporin treatment in steroid-resistant and acutely exacerbated interstitial pneumonia.Intern Med, 2005, 44: 1144-1150.
31.	Inase N, Sawada M, Ohtani Y, et al. Cyclosporin A followed by the treatment of acute exacerbation of idiopathic pulmonary fibrosis with corticosteroid. Intern Med, 2003, 42: 565-570.

1. American Thoracic Society/ European Respiratory Society. American Thoracic Society/ European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med, 2002, 165: 277-304.
2. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med, 2001, 345: 517-525.
3. Kondoh Y, Taniguchi H, Kawabata Y, et al. Acute exacerbation in idiopathic pulmonary fibrosis: analysis of clinical and pathologic findings in three cases. Chest, 1993, 103: 1808-1812.
4. Akira M, Hamada H, Sakatani M, et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis.Am J Roentgenol, 1997, 168: 79-83.
5. Parambil JG, Myers JL, Ryu JH. Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest, 2005, 128:3310-3315.
6. Ambrosini V, Cancellieri A, Chilosi M, et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J, 2003 ,22: 821-826.
7. Kim DS, Park JH, Park BK, et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J,2006, 27: 143-150.
8. Martinez FJ, Safrin S, Weycker D, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med, 2005 ,142: 963-967.
9. Daniels CE, Yi ES, Ryu JH. Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis. Eur Respir J, 2008, 32 :170-174.
10. Collard HR, Moore BB, Flaherty KR, et al. Acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2007 , 176 :636-643.
11. Hyzy R, Huang S, Myers J, et al. Acute exacerbation of idiopathic pulmonary fibrosis. Chest, 2007, 132: 1652-1658.
12. Colby TV. Interstitial disease. In: Colby TV, Lombard CM, Yousem SA, Kitaichi M, eds. Atlas of Pulmonary Surgical Pathology.Philadelphia,WB Saunders, 1991, 227-306.
13. Kitaichi M. Pathologic features and classification of interstitial pnueumonia of unknown etiology. Bull Chest Dis Res Inst Kyoto Univ, 1990, 23: 1-18.
14. Azuma A, Nukiwa T, Tsuboi E, et al. Placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2005, 171: 1040-1047.
15. Kubo H, Nakayama K, Yanai M, et al. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest, 2005, 128: 1475-1482.
16. Rice AJ,Wells AU, Bouros D, et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias. Am J Clin Pathol, 2003 , 119 :709-714.
17. Churg A, Muller NL, Silva CI, et al. Acute exacerbation ( acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am J Surg Pathol, 2007, 31: 277-284.
18. Yonemaru M, Kasuga I, Kusumoto H, et al. Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis. Eur Respir J, 1997, 10: 2040-2045.
19. Tang YW, Johnson JE, Browning PJ, et al. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol, 2003, 41: 2633-2640.
20. McMillan R, Moore BB, Weinberg JB, et al. Exacerbation of established Pulmonary Fibrosis in a Murine Model by Gammaherpesvirus.AmJ Respir Crit Care Med, 2008, 177: 771-780.
21. Raghu G, Freudenberger TD, Yang S, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J, 2006 , 27: 136 -142.
22. Raghu G, Yang ST, Spada C, et al. Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series. Chest, 2006, 129: 794-800.
23. Agarwal R, Jindal SK. Acute exacerbation of idiopathic pulmonary fibrosis: A systematic review. Eur J Intern Med, 2008 , 19: 227 -235.
24. Selman M, Thannickal VJ, Pardo A, et al. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs, 2004 , 64 :405-430.
25. Mehrad B, Burdick MD, Zisman DA, et al. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun, 2007, 353: 104-108.
26. Yuksel M, Ozyurtkan MO, Bostanci K, et al. Acute exacerbation of interstitial fibrosis after pulmonary resection. Ann Thorac Surg,2006, 82: 336-338.
27. Yokoyama A, Kohno N, Hamada H, et al. Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 1998, 158: 1680-1684.
28. Akira M, Kozuka T, Yamamoto S, et al. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2008, 178: 372-378.
29. Wuyts WA, Thomeer M, Dupont LJ, et al. An algorithm to tackle acute exacerbations in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2008, 177: 1397-1397.
30. Homma S, Sakamoto S, Kawabata M, et al. Cyclosporin treatment in steroid-resistant and acutely exacerbated interstitial pneumonia.Intern Med, 2005, 44: 1144-1150.
31. Inase N, Sawada M, Ohtani Y, et al. Cyclosporin A followed by the treatment of acute exacerbation of idiopathic pulmonary fibrosis with corticosteroid. Intern Med, 2003, 42: 565-570.

Previous Article
Effects of Controlled Hypotension on Cerebra: A Systematic Review
Next Article
Effect of Problem-based Learning in Nursing Students: A Meta-analysis

Chinese Journal of Respiratory and Critical Care Medicine

特發性肺纖維化急性加重的研究進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content